Talis Biomedical

$0.00 (0.00%) As of 11:59 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TLIS and other ETFs, options, and stocks.

About TLIS

Talis Biomedical Corp. develops and commercialize innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Menlo Park, CA.

CEO
Robert Kelley
Employees
262
Headquarters
Menlo Park, California
Founded
2013

TLIS Key Statistics

Market cap
61.70M
Price-Earnings ratio
—
Dividend yield
—
Average volume
250.69K
High today
$1.15
Low today
$1.04
Open price
$1.04
Volume
110.33K
52 Week high
$12.88
52 Week low
$0.96

TLIS Earnings

-$10.80
-$7.20
-$3.60
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$1.18 per share
Actual
-$1.25 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure